Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hing Yip Holdings Limited (0132.HK)
Hong Kong, HK
China Investments Holdings Limited, an investment holding company and a subsidiary of Prize Rich Inc., maintains a varied business portfolio spanning Hong Kong and Mainland China. Its operations encompass several key areas, including advanced data solutions such as developing industrial internet platforms, building smart city infrastructure, and managing big data. The company is also a manufacturer and supplier of civil explosives, providing products like emulsion explosives and industrial detonating cords. In the real estate domain, it is involved in property development, possesses investment properties and assets intended for sale, and takes part in the construction and development of industrial parks, alongside property trading. Financial services offered by the company include finance lease consulting and financing, in addition to providing general financial investment services. Furthermore, China Investments Holdings operates and owns hotels, delivers wellness and elderly care services, produces and trades medium density fiberboards, offers transportation for both general and hazardous goods, and generates and sells electricity. The company, founded in 1993, is based in Tsimshatsui, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.74% | +0.51% | -0.50% | +1.53% | -23.46% | -19.76% | -26.30% | -13.48% | -64.46% | -72.74% | +10.56% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+10.6% ★ Q4'25: +14.4% (vs Q4'23)
-
EPS growth Conglomerates: +16.9%-38.1% Q4'25: -60.0% (vs Q4'23)
-
FCF margin FCF growth · Conglomerates: +35.9%-98.1% Q4'25: -128.2% (vs Q4'23)
-
EBIT margin Conglomerates: +9.0%+20.1% ★ Q4'25: +16.3% (vs Q4'23)
-
ROIC Conglomerates: +4.7%+1.5% Q4'25: +2.8% (vs Q4'23)
-
Share dilution Conglomerates: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×28.14× Q4'25: 15.85× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Weiqiang Fu | President, MD & Executive Director | 1M | male |
| Xiangming He | Executive Chairman of the Board | 1M | male |
| Tai On Lo | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0132.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
